Meeting Overview - The third meeting of the Supervisory Board of Hubei Chaozhuo Aviation Technology Co., Ltd. was convened on June 24, 2025, and was legally valid according to relevant laws and regulations [1][2]. Resolutions Passed - The Supervisory Board approved the proposal regarding the second vesting period of the reserved first grant of the 2022 Restricted Stock Incentive Plan, allowing for the vesting of 10,469 shares for two eligible incentive recipients [1][2]. - The proposal to renew the auditing firm for the year 2025 was also approved, pending submission to the shareholders' meeting for further review [2]. - The proposal to abolish the Supervisory Board and revise the company’s articles of association was approved, which also requires submission to the shareholders' meeting [2].

证券代码：688200 证券简称：华峰测控 公告编号：2025-048 北京华峰测控技术股份有限公司 第三届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 表决结果：3 票同意，0 票反对，0 票弃权。 具体内容详见本公司于同日在上海证券交易所网站（www.sse.com.cn）披露 的《关于调整公司 2024 年限制性股票激励计划授予价格及作废处理部分限制性 股票的公告》。 表决结果：3 票同意，0 票反对，0 票弃权。 本议案尚需提交公司 2025 年第二次临时股东大会审议。 北京华峰测控技术股份有限公司（以下简称"公司"）第三届监事会第十三 次会议于 2025 年 6 月 30 日在公司会议室以现场和通讯方式召开。本次会议应到 监事 3 名，实到监事 3 名。会议由监事会主席赵运坤主持。本次会议的召集和召 开符合《公司法》等法律、法规、部门规章以及《公司章程》的有关规定，作出 的决议合法、有效。 二、监事会会议审议情况 经与会监事认真审议，审议通过了以下议案： 表决 ...

Group 1 - The company held its 29th meeting of the third board of directors on June 27, 2025, with all 9 directors present, confirming the legality and validity of the meeting [1] - The board approved the proposal for the election of the fourth board of non-independent directors, with candidates including Yang Meng, Zhao Dongping, Zhu Fanghao, Xiong Kang, and Lian Meng [2][3] - The term for the fourth board of directors will last three years from the date of election at the second extraordinary general meeting of shareholders in 2025 [3] Group 2 - The board also approved the proposal for the election of independent directors, nominating Li Congliang, Yi Xuan, and Han Xi as candidates [2][3] - The remuneration plan for the fourth board of directors was discussed, with non-independent directors receiving an annual allowance of 60,000 yuan and independent directors receiving 84,000 yuan [5] Group 3 - The company plans to abolish the supervisory board, transferring its powers to the audit committee of the board, and will revise the articles of association accordingly [6] - The board approved the proposal to purchase liability insurance for the company and its directors and senior management, with a total insurance limit of 50 million yuan per year and a premium not exceeding 500,000 yuan [8] Group 4 - A three-year shareholder dividend return plan for 2025-2027 was proposed to enhance shareholder return mechanisms [9] - The board proposed to reappoint KPMG Huazhen as the financial and internal control audit institution for the year 2025 [9] Group 5 - The company plans to use up to 1 billion yuan of temporarily idle raised funds for cash management, focusing on safe and liquid financial products [10] - The board approved adjustments to the grant prices of restricted stock incentive plans for 2022, 2023, and 2024 [11] Group 6 - The board approved the vesting of restricted stocks for 249 individuals under the 2022 incentive plan, totaling 1,441,268 shares, and for 144 individuals under the 2023 plan, totaling 1,188,652 shares [12][13] - The board also approved the cancellation of unvested restricted stocks for individuals who have left the company [14] Group 7 - The company plans to hold its second extraordinary general meeting of shareholders on July 16, 2025, to review the relevant matters [15]

| 证券简称：华东医药 | 证券代码：000963 | | --- | --- | | 国盛证券有限责任公司 | | | 关于 | | | 华东医药股份有限公司 | | | 及回购注销部分限制性股票事项 | | | 之 | | | 独立财务顾问报告 | | | 独立财务顾问 | | | （江西省南昌市新建区子实路 | 1589 号） | | 二〇二五年六月 | | | 第一章 | 释义 | | 本财务顾问报告中，除非另有所指，下列词语或简称具有如下含义： | | | 华东医药、公司、上市公司 | 指 华东医药股份有限公司 | | 国盛证券、本独立财务顾问、 | | | 指 | 国盛证券有限责任公司 | | 独立财务顾问 | | | 股权激励计划、激励计划、 | | | 指 | 华东医药股份有限公司 2022 年限制性股票激励计划 | | 本计划 | | | | 公司根据本计划规定的条件和价格，授予激励对象一定数 | | 限制性股票 指 | 量的公司股票，该等股票设置一定期限的限售期，在达到 | | 本计划规定的解除限售条件后，方可解除限售流通 | | | | 按照本计划规定，获得限制性股票的在公司（含下属子公 ...

第一个归属期归属条件成就的公告 前总股本的 0.3777%； 的本公司人民币 A 股普通股股票； 敬请投资者注意。 安克创新科技股份有限公司（以下简称"公司"或"安克创新"）于 2025 年 审议通过了《关于 2024 年限制性股票激励计划首次授予部分第一个归属期归属 条件成就的议案》，根据公司《2024 年限制性股票激励计划（草案）》（以下简 称"《2024 年激励计划》"）、《2024 年限制性股票激励计划实施考核管理办 法》（以下简称"《考核管理办法》"）的规定，本次符合归属条件的首次授予 部分激励对象共 281 人，可申请办理归属的首次授予部分限制性股票共 200.7706 万股，占公司目前总股本的 0.3777%；拟归属的首次授予部分限制性股票授予价 格为 38.52 元/股（调整后）。现将具体情况公告如下： 证券代码：300866 证券简称：安克创新 公告编号：2025-063 安克创新科技股份有限公司 关于 2024 年限制性股票激励计划首次授予部分 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示： ③自可能对本公司股票及其衍生品种 ...

Group 1 - The core opinion of the article is that Weijie Chuangxin (Tianjin) Electronic Technology Co., Ltd. is legally qualified to implement its 2025 restricted stock incentive plan, which has been reviewed and deemed compliant with relevant laws and regulations [5][12][13] - The company was established through a complete change from Weijie Chuangxin (Tianjin) Electronic Technology Co., Ltd. and was approved for its initial public offering by the China Securities Regulatory Commission on March 1, 2022 [5][6] - The company is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board with the stock code "688153" [6] Group 2 - The incentive plan includes specific provisions regarding the eligibility criteria for participants, which consist of management, technical, and business backbone personnel [10][11] - The plan outlines the conditions for the vesting of restricted stocks, including the grant date, grant price, and the duration of validity [7][8] - The plan has undergone necessary legal procedures, including board approval and compliance with disclosure requirements [10][12] Group 3 - The company has confirmed that it will not provide financial assistance to the incentive participants, ensuring compliance with relevant regulations [12] - The plan does not harm the interests of the company or its shareholders, as confirmed by the board's review and the compensation committee's opinion [12][13] - The plan requires approval from the shareholders' meeting through a special resolution before implementation [13]

湖北宜化化工股份有限公司 董事会薪酬与考核委员会关于 2024 年限制性 股票激励计划预留授予激励对象名单 （预留授予日）的核查意见 湖北宜化化工股份有限公司（以下简称"公司"）董事会薪酬与 考核委员会依据《中华人民共和国公司法》（下称"《公司法》"）、 《中华人民共和国证券法》（下称"《证券法》"）、《上市公司股 权激励管理办法》（下称"《管理办法》"）、《湖北宜化化工股份 有限公司 2024 年限制性股票激励计划（草案）》（下称"《激励计 划（草案）》"）等有关规定，对公司 2024 年限制性股票激励计划 （以下简称"本激励计划"）预留授予的激励对象名单（预留授予日） 发表核查意见如下： 一、本激励计划预留授予的激励对象均具备《公司法》 《证券法》 等法律法规、规范性文件规定的任职资格，符合《管理办法》《激励 计划（草案）》等文件规定的激励对象条件。本次激励对象主体资格 合法、有效。 二、公司和本次激励对象均未发生不得授予限制性股票的情形， 本激励计划设定的预留部分授予激励对象获授限制性股票的条件已 经满足。 三、公司董事会确定的预留授予日符合《管理办法》和本激励计 划中有关授予日的规定。 综上，董事会薪 ...

Core Points - The announcement details the first unlock period of the 2024 restricted stock incentive plan for Shanghai Mercury Home Textile Co., Ltd, with 1,738,800 shares to be listed for trading on July 4, 2025 [1][4][11] Group 1: Incentive Plan Approval and Implementation - The incentive plan was approved in the 12th board meeting, with relevant proposals and verification by the supervisory board [1][2] - The supervisory board confirmed the list of incentive objects and the management measures for the implementation of the incentive plan [2][3] Group 2: Unlock Conditions and Achievements - The first unlock period for the restricted stock is set at 12 months, with 40% of the shares eligible for release [4][6] - The conditions for unlocking have been met, including no adverse audit reports and achievement of profit distribution criteria [4][6] Group 3: Specifics of the Unlocking - A total of 65 incentive objects are eligible for unlocking, with 1,738,800 shares representing 0.6620% of the total share capital [4][10] - The unlocking will result in a change in the company's share structure, with restricted shares decreasing and unrestricted shares increasing accordingly [11][12] Group 4: Legal Opinions and Compliance - A legal opinion from Shanghai Jintiancheng Law Firm confirms that all necessary approvals and conditions for the unlocking have been met [11]

北京德恒律师事务所 关于湖北宜化化工股份有限公司 调整授予价格及预留授予的法律意见 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话：010-52682888 传真：010-52682999 邮编：100033 北京德恒律师事务所 关于湖北宜化化工股 份有限公司 北京德恒律师事务所 关于湖北宜化化工股份有限公司 北京德恒律师事务所 关于湖北宜化化工股份有限公司 调整授予价格及预留授予的法律意见 德恒 01F20240297-05 号 致：湖北宜化化工股份有限公司 北京德恒律师事务所（以下简称"本所"）受湖北宜化化工股份有限公司（以 下简称"公司"）的委托，担任公司2024年限制性股票激励计划事项（以下简称 "本激励计划"）的专项法律顾问。根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股权激励管理办法》（以下简称"《管理办法》"）等法律法规、规 范性文件和《湖北宜化化工股份有限公司章程》（以下简称"《公司章程》"）、 《湖北宜化化工股份有限公司2024年限制性股票激励计划（草案）》（以下简称 "《激励计划（草案）》"）的有关 ...

Core Viewpoint - Hubei Yihua Chemical Co., Ltd. has initiated a 2024 restricted stock incentive plan, which includes the reservation of stock grants for eligible employees, aimed at enhancing employee motivation and aligning their interests with shareholders [1][4][5]. Summary by Sections Independent Financial Advisor Report - The independent financial advisor, Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd., has issued a report on the reserved stock grants under the 2024 incentive plan, confirming the legality and accuracy of the provided documents [2][3]. Approval Process - The approval process for the 2024 restricted stock incentive plan involved multiple steps, including the drafting of the plan by the compensation and assessment committee, review by the board of directors, and approval from the shareholders' meeting [5][6][7]. Reserved Grant Details - The total number of reserved restricted stocks is 6.25 million shares, with 6.0125 million shares actually granted, leaving 237,500 shares voided [8][10]. Grant Conditions - The grant of restricted stocks is contingent upon the company and the incentive recipients meeting specific conditions, ensuring that neither party has encountered adverse situations that would disqualify them from receiving the benefits [11]. Financial Impact - The implementation of the stock incentive plan is expected to be accounted for in accordance with relevant accounting standards, with potential dilution effects on existing shareholders being noted [11][12]. Independent Advisor's Opinion - The independent financial advisor has concluded that all necessary approvals for the reserved stock grants have been obtained, and the terms of the grants comply with applicable laws and regulations [11][12].